Software-delivered CBT-I for Insomnia Disorder

NCT ID: NCT05747963

Last Updated: 2024-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

236 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-21

Study Completion Date

2024-03-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this prospective multicenter clinical trial is to evaluate the efficacy and safety of software-delivered cognitive behavioral therapy for insomnia (CBT-I) in Chinese patients with insomnia disorder (ID). The main questions it aims to answer are: (1) whether the software-delivered CBT-I is more effective than an online patient education (online-PE) at improving insomnia. (2) whether the software-delivered CBT-I is safe for treatment of insomnia symptoms.

Participants will be randomized to receive (1) a software-delivered CBT-I using automated software called 'resleep' (one kind of digital device expected to treat insomnia targeted for Chinese patients); (2) online patient education (online-PE) about sleep.

Researchers will compare the efficacy of a software-delivered CBT-I program and an online sleep education control at improving insomnia symptoms and other psychological outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A prospective, multicenter, parallel, randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

software-delivered CBT-I

Subjects in intervention group will receive a digital CBT-I for 6 weeks. The automated software incorporates all core elements of CBT-I, tailoring content based on each participant's reported baseline sleep function and sleep progress.

Group Type EXPERIMENTAL

software-delivered CBT-I

Intervention Type DEVICE

The automated software called 'resleep' incorporates all core elements of CBT-I: sleep restriction, stimulus control, cognitive therapy, relaxation techniques, and sleep hygiene and education, tailoring content based on each participant's reported baseline sleep function and sleep progress. The 6-week treatment includes 42 times of intervention.

online PE

Subjects in control group will receive information about insomnia and sleep health education content.

Group Type ACTIVE_COMPARATOR

online PE

Intervention Type OTHER

Subjects in the control group will receive non-tailored information about insomnia and sleep health education content using the Wechat Official Account.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

software-delivered CBT-I

The automated software called 'resleep' incorporates all core elements of CBT-I: sleep restriction, stimulus control, cognitive therapy, relaxation techniques, and sleep hygiene and education, tailoring content based on each participant's reported baseline sleep function and sleep progress. The 6-week treatment includes 42 times of intervention.

Intervention Type DEVICE

online PE

Subjects in the control group will receive non-tailored information about insomnia and sleep health education content using the Wechat Official Account.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged ≥18 years old, no gender limitation;
* Own a mobile-phone, access the Internet, and be skilled in using software;
* Meet the diagnostic criteria of insomnia disorder in the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5);
* Insomnia symptoms appear at least 3 nights per week and last for at least 3 months;
* ISI scores ≥ 12 ;
* Volunteer to participate in this experiment and sign a written informed consent.

Exclusion Criteria

* Generalized Anxiety Disorder Scale-7 (GAD-7) scores ≥ 15;
* Patients Health Questionnaire-9 (PHQ-9) scores ≥ 20;
* Current thoughts of suicide or self-injury (defined as PHQ-9 9th item score ≥ 1);
* Confirmed physical diseases that may affect sleep, such as congestive heart failure, chronic obstructive pulmonary disease acute phase, cardiovascular and cerebrovascular disease acute phase, etc.
* Current diagnosed neurological or mental illness (major depressive disorder, bipolar disorder, epilepsy, schizophrenia, etc.) that may affect sleep;
* Diagnoses of other untreated sleep disorders, such as obstructive sleep apnea, restless leg syndrome (RLS);
* Usual bedtime (when the subject attempts to fall asleep) is earlier than 8 p.m. or later than 2 a.m., or usual waking (arising) time is earlier than 4 a.m. or later than 10 a.m.
* Alcohol or drug abusers (other than nicotine dependence) in the past year;
* Pregnant or lactating women;
* Undergoing systematic psychotherapy within the past 3 months;
* Undergoing other cognitive behavioral therapy for sleep disorders;
* Unstable usage of medication regimens that affect sleep (changes in type, dosage and method of use within the past 1 month);
* Night shift workers, travelers across time zones;
* Subjects who have not responded to previous CBT-I;
* Other conditions deemed unsuitable for clinical trials by the investigator.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shenzhen Zeen Health Technology Co., Ltd.

UNKNOWN

Sponsor Role collaborator

Peking University First Hospital

OTHER

Sponsor Role collaborator

Sichuan Provincial People's Hospital

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of AFMU

UNKNOWN

Sponsor Role collaborator

Shenzhen Kangning Hospital

OTHER

Sponsor Role collaborator

Peking University Sixth Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hongqiang Sun

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Sixth Hospital

Beijing, Beijing Municipality, China

Site Status

Peking University First Hospital

Beijing, Beijing Municipality, China

Site Status

Shenzhen Kangning Hospital

Shenzhen, Guangdong, China

Site Status

The Second Affiliated Hospital of AFMU

Xi'an, Shaanxi, China

Site Status

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-65

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Digital CBT-I for Chronic Insomnia
NCT06695000 NOT_YET_RECRUITING NA